FSMAX
Price
$115.66
Change
+$1.23 (+1.07%)
Updated
Jun 2 closing price
Net Assets
42.73B
HBMCX
Price
$23.32
Change
+$0.25 (+1.08%)
Updated
Jun 2 closing price
Net Assets
735.55M
Interact to see
Advertisement

FSMAX vs HBMCX

Header iconFSMAX vs HBMCX Comparison
Open Charts FSMAX vs HBMCXBanner chart's image
FSMAX vs HBMCX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. HBMCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a StrongBuy and HBMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 42.7B vs. HBMCX (736M). FSMAX pays higher dividends than HBMCX: FSMAX (0.50) vs HBMCX (0.00). FSMAX was incepted earlier than HBMCX: FSMAX (15 years) vs HBMCX (27 years). HBMCX (1.01) is less costly to investors than FSMAX (0.04). HBMCX is a more actively managed with annual turnover of: 60.00 vs. FSMAX (23.00). FSMAX (0) and HBMCX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 30.51 vs. HBMCX (-11.98). FSMAX return over 5 years is better than : 37.00 vs. HBMCX (-47.85).
FSMAXHBMCXFSMAX / HBMCX
Total Expense Ratio0.041.013%
Annual Report Gross Expense Ratio0.041.013%
Fund Existence15 years27 years-
Gain YTD13.6688.565160%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets42.7B736M5,802%
Annual Yield % from dividends0.500.00-
Returns for 1 year30.51-11.98-255%
Returns for 3 years71.53-9.85-726%
Returns for 5 years37.00-47.85-77%
Returns for 10 years141.36-32.60-434%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RIGGX50.16N/A
N/A
American Funds Intl Gr and Inc R6
CMUAX16.93N/A
N/A
Columbia Select Mid Cap Value A
GPGIX3.89N/A
N/A
Grandeur Peak Global Opportunities Instl
CIGYX11.36N/A
N/A
AB International Growth Advisor
HFDRX20.81N/A
N/A
Hartford Schroders US MidCap Opps R3